- Udyam number
- UDYAM-TS-02-0019013

About Roopa Industries Limited
Data last updated:
Roopa Industries Limited is a public limited company based in Kurnool, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 June 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN L10100AP1985PLC005582. Its GSTIN is 36AAACR9573J1ZV (Telangana). The company holds 3 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 530991.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹7.87 Cr. It was formerly known as Roopa Industries Private Limited. It is led by directors including Tumbalam Gooty Raghavendra (Managing Director) and Joginatha Vaduguri Sarma (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 17/745 Alur Road Adoni, Kurnool, Andhra Pradesh, India – 518301.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹127.5 Cr, a growth of 5.6% compared to the previous year. For the same year it recorded a net profit of ₹4.17 Cr (net margin 3.3%) and EBITDA of ₹4.06 Cr (EBITDA margin 3.2%). The net worth stands at ₹17.6 Cr (up 0.6% YoY). Total assets are valued at ₹49.3 Cr (down 3.9% YoY).
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Roopa Industries. As per MCA filings, the company has open charges of ₹35.65 Cr and satisfied charges of ₹18.06 Cr on record. Court records list 35 cases involving the company, including 13 filed by the company and 22 filed against it; 11 cases are pending. The company has 14 deals on record (14 market trades); the latest was in September 2024. Its 8 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Smruthi Organics Ltd with revenue of ₹126.1 Cr.
Roopa Industries Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0019013). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website roopaindustries.com.
Company details
Recognitions & Rankings of Roopa Industries
Contact details
Roopa Industries Limited's registered office is in Kurnool, Andhra Pradesh. Its website is roopaindustries.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address17/745 Alur Road Adoni, Kurnool, Andhra Pradesh, India – 518301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Roopa Industries Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Roopa Industries operates one associated brand: Roopa Industries. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nutraceuticals, bulk drugs, and chemicals are manufactured in Hyderabad. | roopaindustries.com |
Business activity
The main business activity of Roopa Industries is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Roopa Industries Limited, buy the company report.
Financials of Roopa Industries Limited
FY 2025-26 filings availableRoopa Industries Limited reported revenue of ₹127.5 Cr (up 5.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 128 | 121 | 70.43 | 76.17 | 51.21 | 28.61 | 27.65 |
| Revenue growth | +5.6% | +71.4% | -7.5% | +48.7% | +79.0% | +3.5% | - |
| EBITDA | 4.06 | 4.12 | 4.45 | 3.90 | 3.44 | 2.73 | 1.84 |
| EBITDA margin | +3.2% | +3.4% | +6.3% | +5.1% | +6.7% | +9.5% | +6.7% |
| Profit before tax | 0.17 | 2.73 | 2.19 | 1.82 | 1.36 | 0.94 | 0.81 |
| Net profit | 4.17 | 1.96 | 1.46 | 1.37 | 1.01 | 0.72 | 0.38 |
| Net profit margin | +3.3% | +1.6% | +2.1% | +1.8% | +2.0% | +2.5% | +1.4% |
| EPS (₹) | 0.11 | 2.59 | 1.93 | 1.72 | 1.29 | 0.91 | 0.47 |
| Balance sheet | |||||||
| Total assets | 49.30 | 51.30 | 41.70 | 33.27 | 24.99 | 25.43 | 24.73 |
| Net worth | 17.60 | 17.50 | 15.48 | 13.95 | 12.59 | 11.57 | 10.80 |
| Total debt | 31.02 | 33.26 | 25.75 | 18.87 | 11.97 | 13.46 | 13.51 |
| Cash & bank | 1.54 | 4.62 | 4.15 | 2.73 | 2.01 | 1.00 | 0.73 |
| Net working capital | 41.31 | 42.94 | 26.54 | 19.71 | 15.13 | 15.55 | 14.76 |
| Cash flow | |||||||
| Cash from operations | 4.68 | (6.59) | 2.01 | (0.37) | 2.34 | (0.52) | 2.44 |
| Cash from investing | (0.49) | 2.18 | 1.11 | (0.99) | 3.65 | 1.34 | 0.70 |
| Cash from financing | (7.50) | 4.82 | (2.09) | 1.81 | (5.01) | (0.58) | (3.06) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.30 | 33.32 | 30.14 | 33.54 | 28.74 | 35.07 | 29.83 | 30.73 |
| Revenue growth (YoY) | +19.4% | -5.0% | +1.0% | +9.1% | +12.2% | +1.6% | - | - |
| Other income | 0.00 | 0.02 | 0.11 | 0.00 | 0.00 | 0.02 | 1.14 | 0.92 |
| Total expenses | 32.63 | 31.80 | 31.16 | 31.51 | 27.11 | 33.67 | 29.39 | 29.76 |
| EBITDA | 1.67 | 1.52 | (1.02) | 2.03 | 1.63 | 1.40 | 0.44 | 0.97 |
| EBITDA margin | +4.9% | +4.6% | -3.4% | +6.1% | +5.7% | +4.0% | +1.5% | +3.2% |
| Depreciation | 0.19 | 0.19 | 0.21 | 0.19 | 0.19 | 0.20 | 0.19 | 0.26 |
| Interest | 1.02 | 0.93 | 0.74 | 0.79 | 0.83 | 0.86 | 0.66 | 0.67 |
| Profit before tax | 0.46 | 0.42 | (1.86) | 1.05 | 0.61 | 0.36 | 0.73 | 0.96 |
| Tax | 0.10 | 0.10 | (0.43) | 0.28 | 0.15 | 0.09 | 0.32 | 0.20 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.30 | 33.32 | 30.14 | 33.54 | 28.74 | 35.07 | 29.83 | 30.73 |
| Revenue growth (YoY) | +19.4% | -5.0% | +1.0% | +9.1% | +12.2% | +1.6% | - | - |
| Other income | 0.00 | 0.02 | 0.11 | 0.00 | 0.00 | 0.02 | 1.14 | 0.92 |
| Total expenses | 32.63 | 31.80 | 31.16 | 31.51 | 27.11 | 33.67 | 29.39 | 29.76 |
| EBITDA | 1.67 | 1.52 | (1.02) | 2.03 | 1.63 | 1.40 | 0.44 | 0.97 |
| EBITDA margin | +4.9% | +4.6% | -3.4% | +6.1% | +5.7% | +4.0% | +1.5% | +3.2% |
| Depreciation | 0.19 | 0.19 | 0.21 | 0.19 | 0.19 | 0.20 | 0.19 | 0.26 |
| Interest | 1.02 | 0.93 | 0.74 | 0.79 | 0.83 | 0.86 | 0.66 | 0.67 |
| Profit before tax | 0.46 | 0.42 | (1.86) | 1.05 | 0.61 | 0.36 | 0.73 | 0.96 |
| Tax | 0.10 | 0.10 | (0.43) | 0.28 | 0.15 | 0.09 | 0.32 | 0.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 128 | 121 | 70.43 | 76.17 | 51.21 | 28.61 | 27.65 |
| Revenue growth | +5.6% | +71.4% | -7.5% | +48.7% | +79.0% | +3.5% | - |
| Other income | 0.13 | 2.30 | 1.13 | 0.65 | 0.06 | 0.08 | 1.09 |
| Total expenses | 123 | 117 | 65.98 | 72.27 | 47.77 | 25.88 | 25.81 |
| Employee cost | 2.93 | 2.83 | 3.47 | 3.24 | 2.21 | 3.77 | 2.36 |
| EBITDA | 4.06 | 4.12 | 4.45 | 3.90 | 3.44 | 2.73 | 1.84 |
| EBITDA margin | +3.2% | +3.4% | +6.3% | +5.1% | +6.7% | +9.5% | +6.7% |
| Depreciation | 0.80 | 0.85 | 0.87 | 0.89 | 0.93 | 0.81 | 0.76 |
| Interest | 3.22 | 2.84 | 2.52 | 1.84 | 1.21 | 1.06 | 1.36 |
| Profit before tax | 0.17 | 2.73 | 2.19 | 1.82 | 1.36 | 0.94 | 0.81 |
| Tax | 0.09 | 0.69 | 0.65 | 0.45 | 0.35 | 0.22 | 0.43 |
| Net profit | 4.17 | 1.96 | 1.46 | 1.37 | 1.01 | 0.72 | 0.38 |
| Net profit margin | +3.3% | +1.6% | +2.1% | +1.8% | +2.0% | +2.5% | +1.4% |
| EPS (₹) | 0.11 | 2.59 | 1.93 | 1.72 | 1.29 | 0.91 | 0.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
| Reserves & surplus | 9.73 | 9.63 | 7.61 | 6.08 | 4.72 | 3.70 | 2.93 |
| Shareholders' funds (net worth) | 17.60 | 17.50 | 15.48 | 13.95 | 12.59 | 11.57 | 10.80 |
| Secured loans | 29.55 | 28.02 | 22.59 | 17.75 | 6.04 | 8.14 | 7.52 |
| Unsecured loans | 1.47 | 5.24 | 3.16 | 1.12 | 5.93 | 5.32 | 5.99 |
| Total debt | 31.02 | 33.26 | 25.75 | 18.87 | 11.97 | 13.46 | 13.51 |
| Total liabilities | 49.30 | 51.30 | 41.70 | 33.27 | 24.99 | 25.43 | 24.73 |
| Assets | |||||||
| Gross block | 18.86 | 17.58 | 18.19 | 19.45 | 18.32 | 18.06 | 17.42 |
| Net block | 8.41 | 7.93 | 8.73 | 9.97 | 9.69 | 10.36 | 10.53 |
| Capital work in progress | 0.00 | 0.88 | 0.88 | 0.88 | 0.69 | 0.10 | 0.00 |
| Investments | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Inventories | 30.84 | 36.15 | 25.16 | 18.38 | 15.34 | 19.46 | 12.35 |
| Sundry debtors | 21.92 | 13.00 | 8.35 | 7.08 | 15.68 | 11.50 | 11.90 |
| Cash & bank balances | 1.54 | 4.62 | 4.15 | 2.73 | 2.01 | 1.00 | 0.73 |
| Loans & advances | 8.89 | 13.52 | 10.98 | 13.91 | 5.26 | 3.56 | 2.33 |
| Total current assets | 63.19 | 67.29 | 48.64 | 42.10 | 38.29 | 35.52 | 27.31 |
| Total current liabilities | 21.88 | 24.35 | 22.10 | 22.39 | 23.16 | 19.97 | 12.55 |
| Net working capital | 41.31 | 42.94 | 26.54 | 19.71 | 15.13 | 15.55 | 14.76 |
| Total assets | 49.30 | 51.30 | 41.70 | 33.27 | 24.99 | 25.43 | 24.73 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.38 | 2.98 | 1.95 | 1.49 | 0.50 | 0.26 | 0.17 |
| Net cash from operating activities | 4.68 | (6.59) | 2.01 | (0.37) | 2.34 | (0.52) | 2.44 |
| Net cash from investing activities | (0.49) | 2.18 | 1.11 | (0.99) | 3.65 | 1.34 | 0.70 |
| Net cash from financing activities | (7.50) | 4.82 | (2.09) | 1.81 | (5.01) | (0.58) | (3.06) |
| Net change in cash | (3.31) | 0.40 | 1.03 | 0.45 | 0.99 | 0.25 | 0.08 |
| Closing cash | 1.54 | 4.62 | 4.15 | 2.73 | 2.01 | 1.00 | 0.73 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.6% | +71.4% | -7.5% | +48.7% | +79.0% | +3.5% | - |
| EBITDA growth | -1.5% | -7.4% | +14.1% | +13.4% | +26.0% | +48.4% | - |
| PBT growth | -93.8% | +24.7% | +20.3% | +33.8% | +44.7% | +16.1% | +1.3% |
| Net income growth | +112.8% | +34.3% | +6.6% | +35.6% | +40.3% | +89.5% | - |
| Revenue CAGR (3Y) | +18.7% | +33.1% | +35.0% | +40.2% | +19.3% | +14.7% | -2.7% |
| EBITDA CAGR (3Y) | +1.4% | +6.2% | +17.7% | +28.5% | +11.1% | - | -6.4% |
| Profitability & leverage | |||||||
| Net income margin | +0.1% | +1.7% | +2.2% | +1.8% | +2.0% | +2.5% | +1.4% |
| Return on capital employed | +14.9% | +12.0% | +12.5% | +12.5% | +10.2% | +8.0% | +8.5% |
| Return on net worth | +23.8% | +12.3% | +10.3% | +10.2% | +8.4% | +6.4% | +3.5% |
| Debt / equity | 1.83 | 1.79 | 1.52 | 1.16 | 1.05 | 1.21 | 1.35 |
| Long-term debt / equity | 0.27 | 0.37 | 0.24 | 0.16 | 0.37 | 0.53 | 0.63 |
| Interest cover | 98.77 | 86.85 | 70.39 | 61.13 | 48.21 | 55.21 | 125.93 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 7.00 | 6.75 | 3.74 | 4.03 | 2.82 | 1.61 | 1.85 |
| Inventory turnover | 3.81 | 3.94 | 3.24 | 4.52 | 2.94 | 1.80 | 2.40 |
| Debtors turnover | 7.30 | 11.31 | 9.13 | 6.69 | 3.77 | 2.45 | 2.41 |
| EPS (₹) | 0.11 | 2.59 | 1.93 | 1.72 | 1.29 | 0.91 | 0.47 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 22.37 | 22.24 | 19.67 | 17.73 | 16.00 | 14.70 | 13.73 |
To see the full year-wise statements and ratios of Roopa Industries Limited, buy the company report.
Board of directors of Roopa Industries Limited
Roopa Industries has 5 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karunasree Samudrala Also directs: Samudrala K & Co LLP, Apollo Micro Systems Limited, Eldorado Agritech Limited and 2 more | Director | 26 Aug 2017 | 9 Years 2 Months | Current |
| Joginatha Vaduguri Sarma | Whole-Time Director | 01 Oct 1999 | 27 Years 1 Months | Current |
| Tumbalam Gooty Raghavendra Also directs: A-One Pharmachem Private Limited | Managing Director | 01 Oct 2015 | 11 Years 1 Months | Current |
| Muttaraju Venu Manohar Also directs: Healthy Food Corp Private Limited | Director | 01 Oct 2025 | 1 Years 1 Months | Current |
| Gantla Venkat Reddy | Director | 01 Oct 2025 | 1 Years 1 Months | Current |
Peer comparison
Roopa Industries Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roopa Industries Limitedthis company | ₹127.5 Cr (FY 2026) | ₹4.17 Cr | 3.3% | 5.6% | 23 | Kurnool, Andhra Pradesh, India |
| Smruthi Organics Ltd | ₹126.1 Cr (FY 2025) | -1.0% | Solapur, Maharashtra, India | |||
| Alcon Biosciences Private Limited | ₹125.22 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Super Formulations Private Limited | ₹123.88 Cr (FY 2024) | 17.0% | Ujjain, Madhya Pradesh, India | |||
| Quad Lifesciences Private Limited | ₹123.66 Cr (FY 2025) | 26.0% | Derabassi, Punjab, India | |||
| Richter Themis Medicare (India) Private Limited | ₹122.69 Cr (FY 2025) | -13.0% | Valsad, Gujarat, India | |||
| Nirchem Dyes & Chemicals Private Limited | ₹122.53 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Realcade Lifescience Private Limited | ₹122.35 Cr (FY 2025) | 8.0% | Kadi, Gujarat, India | |||
| Nuray Chemicals Private Limited | ₹122.27 Cr (FY 2025) | 16.0% | Thiruvallur, Tamil Nadu, India |
To see the full peer comparison of Roopa Industries Limited, buy the company report.
Auditor
Roopa Industries Limited is audited by S T Mohite & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S T Mohite & Co. | FY 2023 | 0114108 |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 48.00%, foreign institutional investors hold 0.20%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 51.80%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 48.00% | 48.00% | 48.00% | 48.00% |
| Public | 52.00% | 52.00% | 52.00% | 52.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Apr 2025 | 101086781 | Others | ₹6 Cr | Open | |
| 27 Dec 2024 | 101048925 | Axis Bank Limited | ₹97.3 Lakh | Open | |
| 28 Jul 2017 | 100124814 | Hdfc Bank Limited | ₹28.68 Cr | Open | |
| 30 Jun 2009 | 10167759 | State Bank of India | ₹22.3 Lakh | Satisfied | |
| 20 Mar 2009 | 10155728 | State Bank of India | ₹13.37 Cr | Satisfied |
To see the full charge records of Roopa Industries Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Roopa Industries Limited has 14 deals on record (14 market trades); the latest was in September 2024.
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Market trade | ₹1.61 Cr | Buyer: Multiplier Share and Stock Advisors Private Limited , Neo Apex Share Broking Services LLP , Setu Securities Private Limited Seller: Setu Securities Private Limited , Neo Apex Share Broking Services LLP , Multiplier Share and Stock Advisors Private Limited |
| Jan 2010 | Market trade | ₹9.9 Lakh | Buyer: Star Niochem Private Limited |
| Jul 2007 | Market trade | ₹5.8 Lakh | Seller: an individual |
| Jul 2007 | Market trade | ₹16.7 Lakh | Buyer: M P Vora Shares and Securities Private Limited , an individual Seller: M P Vora Shares and Securities Private Limited , an individual |
| Feb 2007 | Market trade | ₹8.2 Lakh | Buyer: an individual |
To see the full deal history of Roopa Industries Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Roopa Industries Limited has 35 court cases on record: 13 filed by Roopa Industries, 22 filed against it. 11 cases are pending and 24 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 24 | 15 | 2 |
| District courts | 11 | 7 | 9 |
Cases on record (5 of 35)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by Almamet India Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Pentaphos Industries Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Manvibiopharma Pvt. Ltd., Rep. by Sri. Koduru Varun Kumar Reddy | Pending |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against Gordon Woodroffe Logistics Limited | Pending |
| Madras High Court | Civil suit | Filed against the company by Hindustan Unilever Limited, | Pending |
To see the full case history of Roopa Industries Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Roopa Industries Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Roopa Industries Limited has a workforce of 23 employees on its EPFO records as of Mar 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 23 |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Roopa Industries Limited, buy the company report.
GST
Roopa Industries has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACR9573J1ZV | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Roopa Industries Limited, buy the company report.
Recent activity
Roopa Industries Limited has 19 board changes on record since 1999: 14 appointments and 5 cessations. The latest: Gantla Venkat Reddy was appointed as Director on 01 Oct 2025.
27 earlier events are in the company report.
News
Frequently asked questions
Roopa Industries is an active public limited company based in Kurnool, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 June 1985 (41+ years old) and is registered under CIN L10100AP1985PLC005582. Listed on BSE: 530991.
Roopa Industries reported revenue of ₹127.5 Cr for FY 2025-26 (up 5.6% YoY) based on standalone financials.
Roopa Industries has 5 current directors:
- Tumbalam Gooty Raghavendra - Managing Director
- Joginatha Vaduguri Sarma - Whole-Time Director
- Karunasree Samudrala - Director
- Muttaraju Venu Manohar - Director
- Gantla Venkat Reddy - Director
The latest financial statements of Roopa Industries on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Roopa Industries is 36AAACR9573J1ZV, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Roopa Industries is L10100AP1985PLC005582. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Roopa Industries is a listed company as per MCA records. Its shares are listed on BSE (code: 530991).
Roopa Industries has 35 court cases on record: 13 filed by the company and 22 filed against it. 11 are pending. Most are in the high courts.
Roopa Industries was incorporated on 17 June 1985, making it 41+ years old. It is registered with the Registrar of Companies, Vijayawada.
Roopa Industries has 14 deals on record (14 market trades); the latest was in September 2024.
The peers of Roopa Industries by revenue are Smruthi Organics Ltd, Alcon Biosciences Private Limited, Super Formulations Private Limited, Quad Lifesciences Private Limited, Richter Themis Medicare (India) Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

